Rendering

Component: (Network and Table)
Network
100410 - Disclosure - Segment and Other Information (Tables)
(http://www.horizonoharma.com/20161231/taxonomy/role/DisclosureSegmentAndOtherInformationTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001492426 (http://www.sec.gov/CIK)
Segment Reporting [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
Segment Reporting [Abstract]
 
Summary of Total Net Revenue by Medicine

The following table presents a summary of total net revenues by medicine (in thousands): 

 

 

 

Year Ended December 31,

 

 

 

2016

 

 

2015

 

 

2014

 

PENNSAID 2%

 

$

304,433

 

 

$

147,010

 

 

$

—

 

DUEXIS

 

 

173,728

 

 

 

190,357

 

 

 

83,243

 

RAVICTI

 

 

151,532

 

 

 

86,875

 

 

 

—

 

VIMOVO

 

 

121,315

 

 

 

166,672

 

 

 

162,954

 

ACTIMMUNE

 

 

104,624

 

 

 

107,444

 

 

 

25,251

 

KRYSTEXXA

 

 

91,102

 

 

 

—

 

 

 

—

 

RAYOS

 

 

47,356

 

 

 

40,329

 

 

 

19,020

 

PROCYSBI

 

 

25,268

 

 

 

—

 

 

 

—

 

BUPHENYL

 

 

16,879

 

 

 

13,458

 

 

 

—

 

MIGERGOT

 

 

4,651

 

 

 

—

 

 

 

—

 

LODOTRA

 

 

4,193

 

 

 

4,899

 

 

 

6,487

 

QUINSAIR

 

 

1,039

 

 

 

—

 

 

 

—

 

Litigation settlement

 

 

(65,000

)

 

 

—

 

 

 

—

 

Total net revenues

 

$

981,120

 

 

$

757,044

 

 

$

296,955

 

 

  
Summary of Total Net Revenues Attributed to Geographic Sources

The following table presents a summary of total net revenues by geography (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2016

 

 

2015

 

 

2014

 

United States

 

$

964,041

 

 

$

744,036

 

 

$

290,396

 

Rest of world

 

 

17,079

 

 

 

13,008

 

 

 

6,559

 

Total net revenues

 

$

981,120

 

 

$

757,044

 

 

$

296,955

 

 

  
Schedule of Gross Sales from Customers Included in Single Operating Segment

The following table presents the amount and percentage of gross sales from customers that represented more than 10% of the Company’s gross sales included in its single operating segment (in thousands): 

 

 

 

Year ended December 31,

 

 

 

2016

 

 

2015

 

 

2014

 

 

 

Amount

 

 

% of Gross

Sales

 

 

Amount

 

 

% of Gross

Sales

 

 

Amount

 

 

% of Gross

Sales

 

Customer A

 

$

1,413,774

 

 

44

%

 

$

607,771

 

 

30

%

 

$

256,237

 

 

 

43

%

Customer B

 

 

667,031

 

 

21

%

 

 

166,661

 

 

8

%

 

 

105,487

 

 

 

17

%

Customer C

 

 

355,920

 

 

11

%

 

 

207,009

 

 

10

%

 

 

113,751

 

 

 

19

%

Other Customers

 

 

797,463

 

 

24

%

 

 

1,075,853

 

 

52

%

 

 

125,356

 

 

 

21

%

Gross Sales

 

$

3,234,188

 

 

100

%

 

$

2,057,294

 

 

100

%

 

$

600,831

 

 

 

100

%

 

  
Summary of Total Long-Lived Assets by Location

The following table presents total tangible long-lived assets by location (in thousands): 

 

 

 

As of December 31,

 

 

 

2016

 

 

2015

 

United States

 

$

19,542

 

 

$

11,734

 

Ireland

 

 

3,550

 

 

 

1,985

 

Other

 

 

392

 

 

 

301

 

Total long-lived assets (1)

 

$

23,484

 

 

$

14,020

 

 

(1)

Long-lived assets consist of property and equipment.